Eledon Pharmaceuticals (ELDN)
(Delayed Data from NSDQ)
$2.54 USD
-0.15 (-5.58%)
Updated Sep 29, 2025 04:00 PM ET
After-Market: $2.55 +0.01 (0.39%) 6:50 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ELDN 2.54 -0.15(-5.58%)
Will ELDN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ELDN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELDN
Best Momentum Stocks to Buy for July 14th
New Strong Buy Stocks for July 14th
ELDN: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Makes Eledon Pharmaceuticals (ELDN) a New Buy Stock
Other News for ELDN
Is ELDN primed for upward momentum? Crossed Above 20 Day Moving Average shows up after soaring 8.91%
ELDN forms 20 Day Moving Average Resistance on September 26
Is ELDN gaining bearish strength? 20 Day Moving Average Resistance shows up after crashing 5.1%
Is ELDN lining up for a decline? Fell Below 20 Day Moving Average shows up after slipping 1.92%
ELDN Crossed Above 20 Day Moving Average on September 23